Atlas Trials

Pomaglumetad Effects on Glutamate Biomarkers

Clinical trial NCT02919774 · COMPLETED

Trial details

NCT number
NCT02919774
Sponsor
New York State Psychiatric Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Controls
Start date
2016-10-01
Primary completion
2018-04-28
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.